INS and ischemic stroke: Given the above, this pilot trial was designed to determine whether a combination of NMES and insulin therapy would have an effect on glucose metabolism, serum cholesterol and triglycerides concentrations, cardiac hemodynamic parameters, and blood pressure in T2DM patients with hemiplegia caused by an ischemic stroke.